AVBP
ArriVent BioPharma Inc.

133
Mkt Cap
$961.86M
Volume
280,354.00
52W High
$26.33
52W Low
$15.47
PE Ratio
-5.50
AVBP Fundamentals
Price
$23.29
Prev Close
$23.30
Open
$23.34
50D MA
$22.10
Beta
0.90
Avg. Volume
417,604.60
EPS (Annual)
-$2.39
P/B
3.12
Rev/Employee
$0.00
$679.26
Loading...
Loading...
News
all
press releases
ArriVent BioPharma (AVBP) Projected to Post Earnings on Monday
ArriVent BioPharma (NASDAQ:AVBP) will be releasing its Q4 2025 earnings before the market opens on Monday, March 2. (View Earnings Report at...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
ArriVent BioPharma (NASDAQ:AVBP) Trading Up 6.8% - Still a Buy?
ArriVent BioPharma (NASDAQ:AVBP) Stock Price Up 6.8% - What's Next...
MarketBeat·13d ago
News Placeholder
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) DelveInsight
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast...
PR Newswire·14d ago
News Placeholder
ArriVent BioPharma (NASDAQ:AVBP) Shares Down 5.6% - Here's Why
ArriVent BioPharma (NASDAQ:AVBP) Stock Price Down 5.6% - Here's Why...
MarketBeat·16d ago
News Placeholder
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Receives Consensus Rating of "Moderate Buy" from Analysts
ArriVent BioPharma, Inc. (NASDAQ:AVBP - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twelve ratings firms that are currently covering the stock, Marketbeat Ratings...
MarketBeat·18d ago
News Placeholder
$207B Market Shift: The Race for Fast Track Approval in Oncology
$207B Market Shift: The Race for Fast Track Approval in Oncology $207B Market Shift: The Race for Fast Track Approval in Oncology PR Newswire VANCOUVER, BC, Feb. 5, 2026 Issued on behalf of...
PR Newswire·20d ago
News Placeholder
ArriVent BioPharma (NASDAQ:AVBP) Trading Down 5.8% - Here's What Happened
ArriVent BioPharma (NASDAQ:AVBP) Shares Down 5.8% - Should You Sell...
MarketBeat·1mo ago
News Placeholder
ArriVent BioPharma (NASDAQ:AVBP) Shares Up 8.2% - What's Next?
ArriVent BioPharma (NASDAQ:AVBP) Shares Up 8.2% - What's Next...
MarketBeat·1mo ago
News Placeholder
ArriVent BioPharma (NASDAQ:AVBP) Stock Price Down 7.4% - Here's What Happened
ArriVent BioPharma (NASDAQ:AVBP) Trading Down 7.4% - Time to Sell...
MarketBeat·2mo ago
News Placeholder
ArriVent BioPharma (NASDAQ:AVBP) Trading Down 3.2% - What's Next?
ArriVent BioPharma (NASDAQ:AVBP) Trading Down 3.2% - Time to Sell...
MarketBeat·2mo ago
<
1
2
...
>

Latest AVBP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.